Pluripotent stem cell trial for Huntington’s disease

Jascayd gains UK licence for treatment of pulmonary fibrosis

Teva submits FDA application for paediatric Tourette syndrome therapy

Medical-Commercial alignment in rare disease launches: what breaks first?

Engineered AAVs Harness Glymphatic System to Reach Brain Targets in Mice

Ag Genomics Begins to Bear Fruit

Top 10 Best-Selling Drugs 2026

Virtual Cells Go Multiscale to Predict Complex Biology

Advanced Cell Sorting Balances Precision, Scale, and Simplicity

Texas Biomed Enters Into a CRADA with U.S. Dept. of War to Help Protect Against Biological Threats

RBW Consulting: Business Development Manager – Pharmaceutical Manufacturing

Thornshaw Recruitment: Renal Clinical Sales Specialist

Thornshaw Recruitment: Orthopaedic Product Specialist

CHASE: PPA Territory Manager Interventional Oncology – London, Kent, Surrey, Sussex

mexec: Senior Business Development Manager

Chemistree Solutions: Integrated Account Specialist

Chemistree Solutions: Integrated Account Specialist

Bristol Myers Squibb: Senior Therapeutic Area Specialist Dermatology – Boston, MA

CHASE: Territory Manager, Interventional Oncology (South West, Wales and Central)

ICON Plc: Sr Manager, Sales Operation

SGLT2 and GLP-1 medications unlock new potential in CKM care

Orthopedic workforce shortage is real

Secukinumab bests placebo for sustained remission in polymyalgia rheumatica

COVID drop leaves 4 in 5 with cirrhosis missing HCC screening

How to manage refractory migraine in specialty practice

ACP, AMA clarify position on private equity ownership in medicine

FDA clears AI-powered screening software for diabetic retinopathy

Lupin recalls more than 2.5 million eye drops

FDA clears Thunderbolt for treatment of ischemic stroke

Dalbavancin for chronic suppressive antibiotic therapy

Stereotaxis closes Robocath takeover

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Resmed to sell MatrixCare for $490M to private equity firm

CVS CEO says Aetna has a handle on medical costs in advance of Q2 earnings

Whistleblower lawsuit accuses Alignment of accounting fraud

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Resmed to sell software business MatrixCare to private equity firm

Centene exits Arkansas Medicaid expansion program, citing funding challenges

Scientists Race to Test Treatments as Ebola Outbreak Widens

The New Race to Find Treatments for Measles

Medical Advances Are Keeping a Health Reporter Busy

As Ebola Spreads, Scientists Race to Find Vaccines and Treatments

How GLP-1s Feed Our Sick Culture

Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients

A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form

Could Lowering Inflammation Treat Depression?

How the Kratom Industry Won Friends in the Trump Administration

Lawmakers Target the Power of Health Insurance Giants

Farewell Pharma Friends! Beware of the PharmaGovernment Complex!

Farewell Pharma Friends! Beware of the PharmaGovernment Complex!

Why Has There Been a Drop in FDA Enforcement Activity?

Why Has There Been a Drop in FDA Enforcement Activity?

Dancing with Fentanyl: Insys Sales Reps Caught Rapping to Boost Sales

Dancing with Fentanyl: Insys Sales Reps Caught Rapping to Boost Sales

Purdue’s Opioid Marketing is Target of a Federal Criminal Probe

Purdue’s Opioid Marketing is Target of a Federal Criminal Probe

Is The End of Animated Characters in Drug Ads Neigh?

Is The End of Animated Characters in Drug Ads Neigh?